PLOS Medicine publishes research and commentary of general interest with clear implications for patient care, public policy or clinical research agendas.
Contributed equally to this work with:
Unit of Gene Therapy and Stem Cell Biology, Jules Gonin Eye Hospital, Lausanne, Switzerland
Department of Ophthalmology, University of Florida, Gainesville, Florida, United States of America
Department of Ophthalmology, Program in Genetics and Tufts Center for Vision Research, Tufts University School of Medicine, Boston, Massachusetts, United States of America
Unit of Clinical Oculogenetics, Jules Gonin Eye Hospital, Lausanne, Switzerland
Retinal Electrodiagnostics Research Group, Department of Ophthalmology II, Eberhard-Karls University, Tübingen, Germany
Laboratory of Retinal Cell Biology, University Hospital, Zürich, Switzerland
*To whom correspondence should be addressed. E-mail: email@example.com
This question is to determine if you're a human visitor in order to prevent automated spam
Your submission will be reviewed by our staff.
There was a problem with your submission. Please try again later.